The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
Lists
Only you see this
Abstract
Our findings suggest that Rivastigmine may have a role in the management of patients having AD and concomitant mild-severe svCVD, with minimal side effects.
BibTeX
@inproceedings{yatawara2021efficacy,
author = {Chathuri Yatawara and Fatin Zahra Zailan and Esther Vanessa Chua and Linda Lay Hoon Lim and Eveline Franco da Silva and Joanna Sihan Wang and Adeline Su Lyn Ng and Kok Pin Ng and Nagaendran Kandiah},
title = {{The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study}},
booktitle = {Clinical},
year = {2021},
doi = {10.2147/cia.s290055},
}Loading related content...